1
|
Goel S, Mita AC, Mita M, et al: A phase I
study of eribulin mesylate (E7389), a mechanistically novel
inhibitor of microtubule dynamics, in patients with advanced solid
malignancies. Clin Cancer Res. 15:4207–4212. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hadaschik BA, Adomat H, Fazli L, et al:
Intravesical chemotherapy of high-grade bladder cancer with
HTI-286, a synthetic analogue of the marine sponge product
hemiasterlin. Clin Cancer Res. 14:1510–1518. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Den Brok MW, Nuijen B, Meijer DM, Millán
E, Manada C and Beijnen JH: Pharmaceutical development of a
parenteral lyophilised formulation of the investigational
anticancer agent ES-285. HCl PDA J Pharm Sci Technol. 59:246–257.
2005.
|
4
|
Garg V, Zhang W, Gidwani P, Kim M and Kolb
EA: Preclinical analysis of tasidotin HCl in Ewing’s sarcoma,
rhabdomyosarcoma, synovial sarcoma, and osteosarcoma. Clin Cancer
Res. 13:5446–5454. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Huang F, Yang Z, Yu D, Wang J, Li R and
Ding G: Sepia ink oligopeptide induces apoptosis in prostate cancer
cell lines via caspase-3 activation and elevation of Bax/Bcl-2
ratio. Mar Drugs. 10:2153–2165. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sánchez C, Mendoza P, Contreras HR, et al:
Expression of multidrug resistance proteins in prostate cancer is
related with cell sensitivity to chemotherapeutic drugs. Prostate.
69:1448–1459. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nehmé A, Varadarajan P, Sellakumar G, et
al: Modulation of docetaxel-induced apoptosis and cell cycle arrest
by all- trans retinoic acid in prostate cancer cells. Br J Cancer.
84:1571–1576. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tyagi AK, Singh RP, Agarwal C, Chan DC and
Agarwal R: Silibinin strongly synergizes human prostate carcinoma
DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest,
and apoptosis. Clin Cancer Res. 8:3512–3519. 2002.PubMed/NCBI
|
9
|
Dong H, Bai LP, Wong VK, et al: The in
vitro structure-related anti-cancer activity of ginsenosides and
their derivatives. Molecules. 16:10619–10630. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sondhi SM, Singh J, Rani R, Gupta PP,
Agrawal SK and Saxena AK: Synthesis, anti-inflammatory and
anticancer activity evaluation of some novel acridine derivatives.
Eur J Med Chem. 45:555–563. 2010. View Article : Google Scholar
|
11
|
Heo SJ, Kim KN, Yoon WJ, et al: Chromene
induces apoptosis via caspase-3 activation in human leukemia HL-60
cells. Food Chem Toxicol. 49:1998–2004. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Bartek J, Lukas C and Lukas J: Checking on
DNA damage in S phase. Nat Rev Mol Cell Biol. 5:792–804. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Kinloch RA, Treherne JM, Furness LM and
Hajimohamadreza I: The pharmacology of apoptosis. Trends Pharmacol
Sci. 20:35–42. 1999. View Article : Google Scholar : PubMed/NCBI
|
14
|
Dirsch VM, Antlsperger DS, Hentze H and
Vollmar AM: Ajoene, an experimental anti-leukemic drug: mechanism
of cell death. Leukemia. 16:74–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gamet-Payrastre L, Li P, Lumeau S, et al:
Sulforaphane, a naturally occurring isothiocyanate, induces cell
cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer
Res. 60:1426–1433. 2000.PubMed/NCBI
|